Supreme Court to hear 3 cases involving labeling of generic medicines

[JURIST] The US Supreme Court [official website; JURIST news archive] on Friday granted certiorari [order, PDF] in three cases related to the duty of generic drug manufacturers to list possible side effects on the labels of medicines they produce. The three cases, PLIVA Inc. v. Mensing [docket; cert. petition, PDF], Actavis v. Mensing [docket; cert. petition, PDF] and Actavis v. Demahy [docket; cert. petition, PDF] were consolidated and will receive one hour of oral argument time. In each of the…